Ep. 148 - East-West Summit Highlights Part 2

from BioCentury This Week · host BioCentury

As China’s biopharma companies experience their first “biotech winter,” they should be engaged in active portfolio management, stopping projects that will not meet their investors’ expectations, Agio Capital General Manager Henk Joos said on BioCentury This Week. On a special East-West Summit edition of the podcast, Joos and Immune-Onc Therapeutics founder and CEO Charlene Liao discussed pipeline prioritization and other company survival tactics during today’s difficult financing environment.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Nov 18, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 148 - East-West Summit Highlights Part 2

0:00 22:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 22 minutes long.

When was this BioCentury This Week episode published?

This episode was published on November 18, 2022.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!